S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL

oleh: Nigel Russell, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Steven Knapper, Leona Batten, Joanna Canham, Emily Laura Hinson, Ulrik Malthe Overgaard, Amanda Gilkes, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie Freeman, Mike Dennis